Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV004536256 | SCV004118156 | uncertain significance | TYR-related disorder | 2023-03-03 | criteria provided, single submitter | clinical testing | The TYR c.149C>T variant is predicted to result in the amino acid substitution p.Ser50Leu. This variant has been reported in an individual with oculocutaneous albinism (Simeonov et al. 2013. PubMed ID: 23504663); however, a second TYR variant was not reported for this individual. This variant has also been reported along with a second TYR variant in an individual with oculocutaneous albinism (Gao et al. 2017. PubMed ID: 28451379). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Clinical Genetics, |
RCV001699988 | SCV001920573 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001699988 | SCV001974468 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |